ICD-10 Code D68.32

The ICD-10-CM code D68.32 refers to “hemorrhagic disorder due to extrinsic circulating anticoagulants.” Code D68.32 is an International Classification of Diseases, 10th revision, Clinical Modification (ICD-10-CM) code that healthcare providers and medical billers use to represent a specific condition where a patient experiences bleeding complications as a result of anticoagulant medication.

ICD-10-CM D68.32 is categorized under coagulation defects in the ICD-10-CM. This condition arises when patients undergoing anticoagulation therapy — often prescribed to prevent blood clots — experience excessive bleeding. The anticoagulants, which are meant to thin the blood, can sometimes lead to bleeding if the medication’s effects are too strong or improperly managed.

Symptoms of hemorrhagic disorder due to extrinsic circulating anticoagulants can vary but typically include:

These symptoms can be severe and require immediate medical attention to adjust the anticoagulation therapy appropriately.

Several codes are related or similar to ICD-10 D68.32, including:

These codes help in distinguishing between different causes and types of bleeding disorders.

When using D68.32, ensure that the bleeding disorder is directly linked to extrinsic anticoagulant use. Documenting the specific anticoagulant responsible and the clinical circumstances leading to the bleeding is necessary for correct code assignment. 

Use this code when the bleeding is a direct result of the medication, rather than from another underlying condition or cause. Other terms that are assigned to D68.32 are drug-induced hemorrhagic disorder, hemorrhagic disorder due to increase in anti-IIa, hemorrhagic disorder due to increase in anti-Xa, and hyperheparinemia.

A frequent mistake in coding D68.32 is failing to differentiate between intrinsic and extrinsic anticoagulants. Also avoid using this code if the bleeding is not conclusively linked to anticoagulant therapy. Ensure the documentation supports the use of this code by detailing the patient's anticoagulant treatment and the correlation with the bleeding symptoms. Assign additional codes to describe the specific site or type of bleeding, such as hemoptysis or hematuria. The sequencing of code D68.32 and other codes that identify the site or type of bleeding will depend on the circumstances of the encounter. When applicable, assign additional codes to identify adverse effects of the drug.

For accurate coding and billing, the following resources are beneficial:

Use ICD-10 code D68.32 to denote hemorrhagic disorders due to extrinsic circulating anticoagulants. Accurate documentation and understanding of the patient's anticoagulation therapy are critical for proper coding. By following the appropriate guidelines and using available resources, healthcare providers can ensure precise coding and billing practices.

Tebra’s EHR+ gives you quick searches and Systematized Nomenclature of Medicine (SNOMED) field names for efficient code documentation. Plus, Tebra automatically saves ICD-10 to SNOMED mapping for future searches, streamlining your workflow.

Discover how Tebra helps providers effortlessly document health-related issues and conditions in this detailed post.